NAFTA sticking points: A list of impediments holding up a deal
WASHINGTON — The NAFTA negotiations could continue for a while, with U.S. trade czar Robert Lighthizer signalling he wants significant changes in multiple areas and isn’t interested in a quick, limited deal.
Here are some key flashpoints involving Canada:
—Autos: This is the sticking point countries have spent the most effort trying to solve. The U.S. wants to stem the loss of manufacturing jobs to Mexico. Canada broadly shares that goal. However, the issue has prompted some concern, and not only from Mexico. While the U.S. has significantly softened its earlier demands, it still wants 40 per cent of every car built in a high-wage jurisdiction; 75 per cent of all parts to be North American; and 70 per cent of steel to be North American. Critics of the plan say it could backfire: if auto-makers decide they don’t want to deal with all this red tape, they can just ignore NAFTA and simply pay the 2.5 per cent U.S. tariff on cars. Critics say that won’t create jobs — just more expensive cars, and less economic activity.
—Pharmaceuticals: It’s the stated goal of U.S. trade policy to make other countries pay more for drugs, so that foreigners shoulder more of the burden of research and development costs. The U.S. has a particular gripe with Canada: it’s reduced Canada’s ranking in an annual report card on intellectual property, partly over policy changes at Canada’s Patented Medicine Prices Review Board. The U.S. wants more transparency in how drug prices are set in Canada. Its industry is also pushing for greater ability to appeal pricing decisions. Such objectives place it in direct conflict with the Trudeau government, which wants to create a national pharmacare plan and intends to argue that its policy is consistent with that of President Donald Trump, who campaigned on controlling drug prices.